ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,405,197 | +92.8% | 35,911 | +125.7% | 0.00% | +50.0% |
Q4 2022 | $728,702 | +72.3% | 15,914 | +55.7% | 0.00% | +100.0% |
Q3 2022 | $423,000 | -53.3% | 10,222 | +7.6% | 0.00% | -50.0% |
Q2 2021 | $906,000 | -72.4% | 9,500 | -67.0% | 0.00% | -60.0% |
Q1 2021 | $3,277,000 | -37.7% | 28,784 | -24.3% | 0.01% | -44.4% |
Q4 2020 | $5,263,000 | +120.4% | 38,018 | +30.8% | 0.01% | +125.0% |
Q3 2020 | $2,388,000 | +11.1% | 29,059 | +5.7% | 0.00% | +33.3% |
Q2 2020 | $2,150,000 | +104.6% | 27,483 | +16.2% | 0.00% | +50.0% |
Q1 2020 | $1,051,000 | +353.0% | 23,647 | +335.7% | 0.00% | – |
Q4 2019 | $232,000 | -49.8% | 5,427 | -25.5% | 0.00% | -100.0% |
Q2 2019 | $462,000 | +35.1% | 7,283 | -7.3% | 0.00% | – |
Q4 2018 | $342,000 | -34.9% | 7,858 | +14.2% | 0.00% | -100.0% |
Q3 2018 | $525,000 | +67.2% | 6,882 | +7.2% | 0.00% | 0.0% |
Q2 2016 | $314,000 | -73.0% | 6,419 | -65.0% | 0.00% | -50.0% |
Q1 2016 | $1,161,000 | -68.7% | 18,343 | -44.6% | 0.00% | -66.7% |
Q4 2015 | $3,712,000 | +10.8% | 33,093 | -4.8% | 0.01% | -14.3% |
Q3 2015 | $3,349,000 | +44.7% | 34,777 | +53.9% | 0.01% | +40.0% |
Q2 2015 | $2,314,000 | – | 22,592 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |